Form 424B2 JPMORGAN CHASE & CO
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to completion dated October 27, 2026
November , 2026
... (continue reading...)
Form 424B2 ROYAL BANK OF CANADA
Subject to Completion
Preliminary Term Sheet dated
October 28, 2026
Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-275898 (To Prospectus and Prospectus Supplement, each dated December 20, 2023, and Product Supplement EQUITY STR-1 dated June 11, 2025)Units
$10 principal amount per unit CUSIP No.
Pricing Date*
Form 424B3 Prosper Funding LLC
Sales Report: Supplement No.
8 dated
Oct 26, 2026 to Prospectus dated
Sep 02, 2026File pursuant to Rule 424(b)(3)Registration Statement Nos. 333-280336 and 333-280336-01Prosper Funding LLCBorrower Payment Dependent NotesProsper Marketplace, Inc.PMI Management Rights
This Sales Report supplements the prospectus dated
Sep 02, 2026
and provides information about each series of Borrower Payment... (continue reading...)
Form 424B2 BofA Finance LLC
http://archive.fast-edgar.com/20261028/AJZ2BQ2CJW22DZZ2222M2ZZH9JMHW22IV282
Filed on: October 28, 2026
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: BANK OF AMERICA CORP /DE/
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
More SEC Filings
View Older Stories-
Form SCHEDULE 13G/A FRANKLIN STREET PROPERTI Filed by: BANK OF AMERICA CORP /DE/
-
Form 424B2 Jefferies Financial Grou
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: BANK OF AMERICA CORP /DE/
-
Form 4 Vir Biotechnology, Inc. For: Oct 27 Filed by: Topalian Suzanne Louise
-
Form 485BPOS GraniteShares ETF Trust
-
Form 13F-HR Moss Adams Wealth Adviso For: Sep 30
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D Verdant Resource Partner
-
Form 424B3 Prosper Funding LLC
-
Form 3 Vir Biotechnology, Inc. For: Oct 27 Filed by: Topalian Suzanne Louise
-
Form 13F-HR SBI Holdings USA, Inc. For: Sep 30
-
Form 424B2 BofA Finance LLC
-
Form 424B2 BARCLAYS BANK PLC
-
Form 13F-HR Tributary Capital Manage For: Sep 30
-
Form N-CSR Cavanal Hill Funds For: Aug 31
-
Form 6-K BCE INC For: Oct 28
-
Form TA-1/A Plural Transfer Services
-
Form 424B2 BofA Finance LLC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 BofA Finance LLC
-
Form 424B2 TORONTO DOMINION BANK
-
Form 485BPOS MUTUAL FUND SERIES TRUST
-
Form 485BPOS GraniteShares ETF Trust
-
Form 424B2 WELLS FARGO & COMPANY/MN
-
Form 4 DRDGOLD LTD For: Oct 25 Filed by: Mashatola Mpho
-
Form D GHCI HEALTHCARE FUND
-
Form 424B2 BARCLAYS BANK PLC
-
Form 485BPOS CCM INVESTMENT TRUST
-
Form NPORT-P ASA Gold & Precious Meta For: Aug 31
-
Form 424B2 BofA Finance LLC
-
Form 497AD AETOS LONG/SHORT STRATEG
-
Form 485BPOS NUVEEN INVESTMENT TRUST
-
Form 10-Q HF Sinclair Corp For: Sep 30
-
Form 485BPOS NUVEEN INVESTMENT TRUST
-
Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC
-
Form 424B2 BofA Finance LLC
-
Form D CVC Capital Partners X
-
Form 497AD AETOS DISTRESSED INVESTM
-
Form MA-I STIFEL, NICOLAUS & COMPA
-
Form 13F-HR Transcendent Capital For: Sep 30
-
Form FWP MORGAN STANLEY Filed by: MORGAN STANLEY
-
Form MA-I/A SAMCO CAPITAL MARKETS,
-
Form 424B2 CITIGROUP INC
-
Form ABS-EE Hyundai Auto Receivables For: Sep 30
-
Form 13F-HR Prodigy Asset Management For: Sep 30
-
Form 497AD AETOS MULTI-STRATEGY
-
Form 486BPOS Accordant ODCE Index
-
Form 424B2 BARCLAYS BANK PLC
